SCD Roundup

By Ahmar U. Zaidi, MD “No conclusions can be drawn from this case. Not even a definite diagnosis can be made,” James Herrick wrote in 1910 about the case of the first known patient in America with sickle cell disease (SCD), Walter Clement Noel. More than one century...

Invisible Warriors

By Alexander K. Glaros, MD, and Ahmar U. Zaidi, MD In the social media community of patients with sickle cell disease (SCD) and their advocates, the moniker of “sickle cell warrior” has been widely adopted to unify those who struggle daily with the burden of this...

ASH Research Collaborative Sickle Cell Disease Clinical Trials Network

The ASH Research Collaborative (ASH RC) was established by ASH in 2018 with the goal of fostering collaborative partnerships to accelerate progress in hematology and improve lives of those affected by blood diseases. The ASH RC has two main components: the Data Hub...
The Cure Sickle Cell Initiative: Rewriting an Old Story

The Cure Sickle Cell Initiative: Rewriting an Old Story

The Cure Sickle Cell Initiative (CureSCi; ) was created by the National Heart, Lung, and Blood Institute to accelerate the development of treatments aimed at a genetic- based cure for sickle cell disease (SCD), and ASH has partnered with the Initiative in an effort to...

ASH Clinical Practice Guidelines Update

ASH has long recognized the need for comprehensive guidelines and in the past three years has broken ground on developing and/or updating guidelines on several disease types, including venous thromboembolism (VTE), immune thrombocytopenia (ITP), acute myeloid leukemia...

ASH RC Update

The ASH Research Collaborative (ASH RC) is a nonprofit organization established by ASH in 2018 to foster collaborative partnerships to accelerate progress in hematology and improve the lives of people affected by blood diseases. This two-part initiative consists of...